Molecular conjugates: a targeted gene delivery vector for molecular medicine
- PMID: 8581509
- DOI: 10.1007/BF00198899
Molecular conjugates: a targeted gene delivery vector for molecular medicine
Similar articles
-
Protein/DNA polyplexes for gene therapy.Surg Oncol Clin N Am. 2002 Jul;11(3):697-716, viii. doi: 10.1016/s1055-3207(02)00022-4. Surg Oncol Clin N Am. 2002. PMID: 12487063 Review.
-
Targeted, non-viral gene delivery for cancer gene therapy.Front Biosci. 1998 Nov 15;3:D1161-70. doi: 10.2741/a352. Front Biosci. 1998. PMID: 9820737 Review.
-
Recent developments and current status of gene therapy using viral vectors in the United Kingdom.BMJ. 2004 Oct 9;329(7470):839-42. doi: 10.1136/bmj.329.7470.839. BMJ. 2004. PMID: 15472267 Free PMC article. Review. No abstract available.
-
Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway.Gene Ther. 1994 Jul;1(4):223-32. Gene Ther. 1994. PMID: 7584085 Review.
-
Intracellular trafficking of nonviral vectors.Gene Ther. 2005 Dec;12(24):1734-51. doi: 10.1038/sj.gt.3302592. Gene Ther. 2005. PMID: 16079885 Review.
Cited by
-
Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.J Virol. 2002 Dec;76(24):12900-7. doi: 10.1128/jvi.76.24.12900-12907.2002. J Virol. 2002. PMID: 12438615 Free PMC article.
-
Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose.Glycoconj J. 2001 Sep;18(9):731-40. doi: 10.1023/a:1020879524587. Glycoconj J. 2001. PMID: 12386459 Review.
-
Mixtures of poly(triethylenetetramine/cystamine bisacrylamide) and poly(triethylenetetramine/cystamine bisacrylamide)-g-poly(ethylene glycol) for improved gene delivery.Bioconjug Chem. 2010 Oct 20;21(10):1753-61. doi: 10.1021/bc900522x. Bioconjug Chem. 2010. PMID: 20882996 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical